Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissue

Journal of Chemotherapy

Volumn 14, Issue 1, 2002, Pages 54-58

  Boselli, E ^a   Breilh, D ^a   Debon, R ^a   Duflo, F ^a   Bel, J C ^a   Saux, M C ^a   Chassard, D ^a   Allaouchiche, B ^a  

^a HÔTEL DIEU   (France)

Author keywords

Antibiotics; Diffusion; Piperacillin tazobactam; Synovial tissue

Indexed keywords

PIPERACILLIN; TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG PENETRATION; FEMALE; HUMAN; INFECTION PREVENTION; INFECTIOUS ARTHRITIS; MALE; MICROANGIOPATHY; POSTOPERATIVE INFECTION; TOTAL HIP PROSTHESIS;

EID: 0036193865     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.1.54     Document Type: Article

References (10)

1. Diffusion in bone tissue of antibiotics
2. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam
3. Micro-organisms responsible for osteo-articular infections
4. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery
5. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues
6. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data
7. In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates
8. Piperacillin/tazobactam: A critical review of the evolving clinical literature
9. Penetration of piperacillin/tazobactam into cancellous and cortical bone tissue
10. A 10 year retrospective comparison of the diagnostic usefulness of synovial fluid and synovial biopsy examination